arrow
M

Marianna Alunni-Fabbroni

Ludwig Maximilian University of Munich
H指数:23
被引数:2,464

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab

血清IL-6是接受阿替利珠单抗和贝伐珠单抗治疗的晚期肝细胞癌的预后生物标志物

2025-10-110
OAAI
In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

患者血清的体外特性可预测高剂量率近距离放射治疗后肝细胞癌的临床结局

2025-09-010
OAAI
Conditioned medium from brachytherapy-irradiated hepatocellular carcinoma cells drives SASP-mediated senescence in naïve cellular counterparts

брахиотерапевтически облученных клеток гепатоцеллюлярной карциномы приводит к сенесценции naïve-клеток за счет SASP

2025-07-300
OAAI
Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity

阿特珠单抗/贝伐珠单抗治疗肝细胞癌的早期死亡率与肝功能受损及全身免疫改变相关

2025-07-010
OAAI
Nuclear magnetic resonance-based lipid metabolite profiles for differentiation of patients with liver cirrhosis with and without hepatocellular carcinoma

基于核磁共振的脂质代谢物谱,用于区分有无肝细胞癌的肝硬化患者

2025-04-040
OA
Impact of Helicobacter pylori on Immune Checkpoint Inhibition in Hepatocellular Carcinoma: A Multicenter Study
2025-02-190
PRE
Transgenic pigs expressing near infrared fluorescent protein-A novel tool for noninvasive imaging of islet xenotransplants

表达近红外荧光蛋白的转基因猪-一种用于胰岛异种移植物无创成像的新工具

2021-12-213
OAAI
RE: Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis Response

RE: 随访期间高危早期乳腺癌中循环肿瘤细胞的存在和预后反应

2019-06-111
OAAI
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis
2018-10-11103
PREAI